Efficacy and tolerability of adding coenzyme A 400 U/d capsule to stable statin therapy for the treatment of patients with mixed dyslipidemia: an 8-week, multicenter, double-Blind, randomized, placebo-controlled study

Meta-Analysis of Safety of the Coadministration of Statin With Fenofibrate in Patients With Combined Hyperlipidemia

(2012) Jinrui Guo et al.   AMERICAN JOURNAL OF CARDIOLOGY

Mortality risk of triglyceride levels in patients with coronary artery disease

(2012) Takatoshi Kasai et al.   HEART

LDL Cholesterol: The Lower the Better

(2012) Seth S. Martin et al.   MEDICAL CLINICS OF NORTH AMERICA

Triglycerides and Cardiovascular Disease

(2011) Michael Miller et al.   CIRCULATION

Fenofibrate

(2011) Kate McKeage et al.   DRUGS

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Antisense therapy in the treatment of hypercholesterolemia

(2011) Giuseppe Lippi et al.   European Journal of Internal Medicine

Safety review of combination drugs for hyperlipidemia

(2011) Michel Farnier   Expert Opinion On Drug Safety

Effects of Prescription Omega-3-Acid Ethyl Esters on Non—High-Density Lipoprotein Cholesterol When Coadministered With Escalating Doses of Atorvastatin

(2010) Harold E. Bays et al.   MAYO CLINIC PROCEEDINGS

Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia

(2008) Philip Barter et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

(2008) Jean-Charles Fruchart et al.   Diabetes & Vascular Disease Research

Prescription omega-3 acid ethyl esters plus simvastatin 20 and 80 mg: effects in mixed dyslipidemia

(2008) Kevin C. Maki et al.   Journal of Clinical Lipidology